Use of Renin–Angiotensin–Aldosterone System Inhibitors in Older Patients with Heart Failure and Reduced Ejection Fraction
Patients enrolled in randomised clinical trials may not be representative of the real-world population of people with heart failure (HF). Older patients are frequently excluded and this limits the strength of evidence which supports the use of specific HF treatments in this patient group. Lack of ev...
Saved in:
| Main Authors: | Davide Stolfo, Gianluigi Savarese |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Radcliffe Medical Media
2019-05-01
|
| Series: | Cardiac Failure Review |
| Online Access: | https://www.cfrjournal.com/articles/Renin-Angiotensin-Aldosterone-Heart-Failure-HFrEF |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evidence-based Therapy in Older Patients with Heart Failure with Reduced Ejection Fraction
by: Davide Stolfo, et al.
Published: (2022-04-01) -
Hyperkalemia and Renin–Angiotensin–Aldosterone System Inhibitors Dose Therapy in Heart Failure With Reduced Ejection Fraction
by: Giuseppe MC Rosano, et al.
Published: (2019-11-01) -
Sodium Zirconium Cyclosilicate for Renin–Angiotensin–Aldosterone System Inhibitor Optimization in Patients with Heart Failure with Reduced Ejection Fraction: A Retrospective Analysis
by: Rhys Williams, et al.
Published: (2024-11-01) -
Comparative analysis of mineralocorticoid receptor antagonists and renin-angiotensin system inhibitors/angiotensin receptor neprilysin inhibitor in heart failure with mildly reduced ejection fraction
by: Chia-Chen Lee, et al.
Published: (2024-12-01) -
Effect of combination antihypertensive therapy, including renin-angiotensin-aldosterone system inhibitors, on oxidative stress and arterial remodeling in hypertensive patients with heart failure with preserved ejection fraction
by: Z. M. Akhilgova, et al.
Published: (2021-06-01)